image by: Howard Lake

HWN Suggests

An Ongoing Revolution in Blood Cancer

In cancer research, blood cancers have always stood apart. The group, which includes leukemia, lymphoma and myeloma, corrupt various cells within the blood, lymph nodes and bone marrow. For patients, hematological malignancies, like their solid tumor counterparts, are diverse. Some are easy to treat; some are nearly impossible. Some move quickly; some exist for decades, unnoticed.

For researchers, blood cancers can be a broad target. Because such malignancies circulate throughout a patient’s system, they can be relatively easy to access and study. Drug delivery can be easier too. Blood cancers also tend to be less biologically complex than solid tumors, with fewer redundant pathways.…

read full article

Featured

 The Landscape of Blood Cancer Research Today—and Where the Field Is Headed

This is an immensely exciting time in the study of hematologic malignancies, marked by tremendous progress in basic, translational, and clinical research. To highlight just a few major advances, engineered T-cell treatments and other immunotherapies, along with targeted therapies, represent definitive progress in the clinical realm.

 What Your Blood Tells You About Cancer

Ultimately, say officials from both Guardant and Foundation Medicine, the goal is to look to the blood not only as a guide for which drugs to use for which patients, but to screen for cancer at even earlier stages, before it’s diagnosed.

Articles of Interest

10 Questions You Always Wanted to Ask a Blood Cancer Survivor

Watch as two-time cancer survivor Kierran, shares his story - how he stayed positive and what stem cell transplantation has to do with why he's still here today.

A blood cancer diagnosis helped me find true happiness

Suddenly, I could see my previous life – of pointless anxieties, petty rivalries and overthinking – for what it was.

AI Virtual Patient Platform Aims to Help Treat Deadly Blood Cancer

Gemini uses casual AI to reconstruct an individual patient and to stimulate how the disease progresses through each patient’s body, and which types of therapies might treat the disease.

Blood Cancers Are On the Rise—Here Are Some Common Symptoms to Know

Everyday occurrences like nosebleeds, fatigue, and UTIs might indicate something serious going on.

Blood Cancers: Symptoms, Diagnosis and Treatment

When cancer occurs in the blood, it’s usually the result of an abnormal and excessive reproduction of white blood cells. Blood cancers account for about 10 percent of all diagnosed cancers in the U.S. each year. Blood cancers (including leukemia, lymphoma and myeloma) are more common in men than women. Childhood leukemia accounts for about 25 percent of all cancers in children.

What can go wrong in the blood? A brief overview of bleeding, clotting and cancer

Blood cancers occur when there is an uncontrolled growth of blood cells, which can infiltrate tissues and cause disease. The main types of blood cancer are leukaemia, lymphoma and myeloma.

Resources

4 Things to Know About a Rare Blood Cancer Diagnosis

If you’re living with polycythemia vera, myelofibrosis, or essential thrombocythemia, you may have never heard of your condition before being diagnosed—which makes sense. Collectively known as myeloproliferative neoplasms, or MPNs, these rare blood cancers are, well, very rare. About 20,000 Americans are diagnosed with an MPN each year. (For some context, in 2024, an estimated 313,510 people in the US will learn that they have breast cancer.)

7 Facts You Need to Know About Blood Cancers

There are no effective screening tests for the early detection of blood cancers.

Blood Cancer Discovery

Blood Cancer Discovery publishes high-quality Research Articles and Briefs representing major advances in basic, translational, and clinical research of leukemia, lymphoma, myeloma, and associated diseases. T

Blood Cancer UK

We're a community dedicated to beating blood cancer by funding research and supporting those affected. Since 1960, we've invested over £500 million in blood cancer research, transforming treatments and saving lives.

Anthony Nolan

Anthony Nolan, saving the lives of people with blood cancer.

DKMS

DKMS is an international not for profit organization dedicated to the fight against blood cancer and blood disorders by: creating awareness; recruiting bone marrow donors to provide a second chance at life; raising funds to match donor registration costs; supporting the improvement of therapies through research; and supporting patients from day one of their diagnoses.

Cancer Treatment Centers of America

The three main types of blood and bone marrow cancer are leukemia, lymphoma and myeloma:

Hematology.org

In most blood cancers, the normal blood cell development process is interrupted by uncontrolled growth of an abnormal type of blood cell. These abnormal blood cells, or cancerous cells, prevent your blood from performing many of its functions, like fighting off infections or preventing serious bleeding.